IGF2BP1 and non-small cell lung carcinoma: Five DEMGs (HNRNPA2B1, HNRNPC, IGF2BP1, METTL3 and RBM15B) were selected as the optimal DEMGs for predicting the prognosis of NSCLC by using LASSO regression model.